Testosterone doping: dealing with genetic differences in metabolism and excretion
Bowers, L.D.
Journal of Clinical Endocrinology and Metabolism 93(7): 2469-2471
2008
ISSN/ISBN: 0021-972X
PMID: 18617700
DOI: 10.1210/jc.2008-0977
Accession: 056152711
PDF emailed within 0-6 h: $19.90
Related References
Starcevic, B.; Butch, A.W. 2008: Genetic variations in UDP-glucuronosyl transferase 2B17: implications for testosterone excretion profiling and doping control programs Clinical Chemistry 54(12): 1945-1947Hamburger, C.; Birket-Smith, E.; Kaee, S. 1952: Testosterone treatment and 17-ketosteroid excretion. III. Comparison of the time of absorption and excretion of testosterone propionate, testosterone-iso-butyrate, and testosterone-n-valerate Acta Endocrinologica 9(1): 79-98
Schubert, K.; Schroeder, H. 1959: Steroid metabolism in breast cancer. III. The excretion of fractionated 17-ketosteroids as well as testosterone overflow in graduated testosterone load Acta Endocrinologica 32: 23-32
Laczmański, Łu.; Medraś, M. 2009: Testosterone metabolism and doping test results Endokrynologia Polska 60(1): 58-62
Delbeke, F.T.; Debackere, M. 1986: The influence of diuretics on the excretion and metabolism of doping agents. II. Phentermine Arzneimittel-Forschung 36(1): 134-137
Delbeke, F.T.; Debackere, M. 1985: The influence of diuretics on the excretion and metabolism of doping agents - I. Mephentermine Journal of Pharmaceutical and Biomedical Analysis 3(2): 141-148
Delbeke, F.T.; Debackere, M. 1986: The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine Arzneimittel-Forschung 36(9): 1413-1416
Delbeke, F.T.; Debackere, M. 1991: The influence of diuretics on the excretion and metabolism of doping agents--V. Dimefline Journal of Pharmaceutical and Biomedical Analysis 9(1): 23-28
Hamburger, C. 1956: Testosterone treatment and 17-ketosteroid excretion. IV. Administration of testosterone beta-cyclopentylpropionate, testosterone furanate, and testosterone oenanthate Acta Endocrinologica 22(4): 379-389
Hamburger, C. 1956: Testosterone treatment and 17-ketosteroid excretion. IV. Administration of testosterone -cyclo-pentylpropionate, testosterone furanate, and testosterone oenanthate Acta Endocrinol 22(4): 379-389
Delbeke, F.T.; Debackere, M. 1988: The influence of diuretics on the excretion and metabolism of doping agents. Part IV--Caffeine Biopharmaceutics and Drug Disposition 9(2): 137-145
Delbeke, F.T.; Debackere, M. 1991: The influence of diuretics on the excretion and metabolism of doping agents: Part VI. Pseudoephedrine Biopharmaceutics and Drug Disposition 12(1): 37-48
Hamburger, C.; Kaae, S. 1949: Testosterone treatment and 17-ketosteroid excretion; investigations on the influence of the mode of administration upon the absorption and excretion of testosterone propionate Acta Endocrinologica 2(3): 257-286
Kintz, P. 2000: Evidence of testosterone and testosterone esters doping through hair analysis Science and Sports 15(3): 162-164
Moehle, U.; Heistermann, M.; Palme, R.; Hodges, J.K. 2000: Characterisation of testosterone metabolism and excretion in male non-human primates Folia Primatologica 71(4): 202